GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-799 Cr | ₹15 Cr | ₹35 Cr | ₹1,238 Cr | ₹-6.87 Cr |
What is the latest Cash Flow from Financing Activities ratio of GLAND PHARMA ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-799 Cr |
Mar2023 | ₹15 Cr |
Mar2022 | ₹35 Cr |
Mar2021 | ₹1,238 Cr |
Mar2020 | ₹-6.87 Cr |
How is Cash Flow from Financing Activities of GLAND PHARMA Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-799 Cr | Negative | |
Mar2023 | ₹15 Cr | -57.25 | |
Mar2022 | ₹35 Cr | -97.18 | |
Mar2021 | ₹1,238 Cr | Positive | |
Mar2020 | ₹-6.87 Cr | - |
Compare Cash Flow from Financing Activities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹34,683.0 Cr | 3.2% | 14.9% | 1.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,466.0 Cr | 1.7% | 2% | -0.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹177,298.0 Cr | 0.4% | -2% | 37.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹127,538.0 Cr | 6% | 10.5% | 13.6% | Stock Analytics | |
CIPLA | ₹127,140.0 Cr | 6.8% | 4.6% | -0.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,500.0 Cr | 4.2% | 1.3% | -6.7% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 3.2% |
14.9% |
1.6% |
SENSEX | -1% |
-3.2% |
1.6% |
You may also like the below Video Courses